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Abstract 
The aim of this study was to evaluate the effects of increasing dietary arachidonic acid (ARA) levels (from 1 up to 6 % 
of total fatty acids) on European sea bass (Dicentrarchus labrax) juveniles growth performance, tissue fatty acid profile, 
liver morphology as well as long chain polyunsaturated fatty acids (LC-PUFA) biosynthesis, triglyceride and 
cholesterol synthesis and lipid transport. A diet with total fish oil (FO) replacement and defatted fish meal (FM) 
containing a 0.1 g ARA g
-1
 diet was added to the experimental design as a negative control diet. Dietary ARA 
inclusion levels below 0.2 g ARA g
-1
 diet significantly worsened growth even only 30 days after the start of the 
feeding trial, whereas dietary ARA had no effect on fish survival. Liver, muscle and whole body fatty acid profile 
mainly reflected dietary contents and ARA content increased accordingly with ARA dietary levels. Tissue 
eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) levels were positively 
correlated among them. Hepatic lipid vacuolization increased with reduced dietary ARA levels. Expressions of fatty 
acyl desaturase 2 and 3-hydroxy-3-methylglutaryl-coenzyme genes were up-regulated in fish fed the negative control 
diet compared to the rest of the dietary treatments denoting the influence of ARA on lipid metabolism. Results obtained 
highlight the need to include adequate n-6 levels and not only n-3 LC-PUFA levels in European sea bass diets.   
Keywords: Dicentrarchus labrax, arachidonic acid, growth performance, tissue fatty acid profile, lipid metabolism 
 
Abbreviations:  
LC-PUFA: Long-chain polyunsaturated fatty acid  
DHA: Docosahexaenoic acid 
ARA: Arachidonic acid 
EPA: Eicosapentaenoic acid 
DPA: Docosapentaenoic acid 
HSI: Hepatosomatic index 
PFI: Perivisceral fat index 
VSI: Viscerosomatic index 
K: Condition factor 
SGR: Specific growth rate 
FCR: Feed conversion ratio 
fads2:fatty acid desaturase gene 
gck: glycerol kinase gene 
hmgrc: 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene 
fabp7: fatty acid binding protein gene 
 
1. Introduction 
Dietary long chain polyunsaturated fatty acids (LC-PUFA) are necessary for fish growth and development, as 
well as for an efficient functioning of fish lipid metabolism and immune system (Higgs and Dong 2000; Kiron et al. 
2011; Tian et al. 2014). However, during the last decades, a plethora of studies has focused on the effects of n-3 LC-
PUFA deposition in fish (Izquierdo and Koven, 2011; Morais et al. 2011; Betancor et al. 2015a,b; 2016a,b) and limited 
attention has been paid to the effects that low levels of n-6 LC PUFA, in particular arachidonic acid (ARA; 20:4n-6) 
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can have on teleost fish species (Montero and Izquierdo, 2010; Izquierdo and Koven, 2011). Furthermore the optimum 
ARA inclusion levels have not been estimated for juveniles of marine fish as most of the requirement studies have been 
performed on larvae (Bessonart et al. 1999: Atalah et al. 2011; Yuan et al. 2015).  
ARA is an essential fatty acid for fish as appropriate levels of this FA are required to achieve proper growth 
performance, development and survival (Carrier et al. 2011; Boligno et al. 2014; Lund et al. 2007, 2010; Rombenso et 
al. 2016), lipid metabolism (Martins et al. 2012; Norambuena et al. 2012), reproduction (Furita et al. 2003; Norambuena 
et al. 2012, 2013) stress resistance (Koven et al. 2001, 2003; Rezek et al. 2010), immune system function (for review 
see Montero and Izquierdo 2010) as well as resistance to disease (Xu et al. 2010). It also is the main precursor for the 
synthesis of 2-series prostaglandins (Smith et al. 2002) and is known to affect signaling pathways and membrane-
associated enzyme activities by modifying the fatty acid profile of cell membranes (Waagbø 2006; Calder 2008). 
Furthermore, not only the individual amounts of ARA have an effect on fish, but an interaction also exists between this 
and the n-3 LC-PUFA eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3). In this sense, a 
recent study in Atlantic salmon (Salmo salar) showed that combined dietary inclusion of ARA and EPA improved fish 
performance and changed tissue fatty acid composition (Norambuena et al. 2016). On the other hand, a high EPA/ARA 
ratio caused reduced growth in gilthead sea bream (Sparus aurata) juveniles fed feeds containing a de novo oil derived 
from a GM-oilseed crop (Betancor et al. 2016b). This fact is even more obvious in carnivorous fish species given that 
these have limited availability to biosynthesize n-3 and n-6 LC-PUFA from their precursors in the feeds by the action of 
fatty acid desaturases and elongases (Mourente et al. 2005). Additionally, the marginal deficiency of essential fatty 
acids can lead to health related problems in farmed fish including alterations on stress resistance (Montero et al. 2015), 
gut integrity (Caballero et al. 2002; Torrecillas et al. 2016) or lipid metabolism (Caballero et al. 2006). Indeed, ARA is 
known to modify metabolic functions in fish by altering the expression of genes belonging to several pathways 
(Betancor et al. 2014; Salini et al. 2016) and thus is worthy to evaluate the effect that increasing ARA levels can have 
on genes involved in LC-PUFA biosynthesis, lipid transport and synthesis as well as cholesterol metabolism. 
Thus, the present study aimed to examine the effect of graded levels of dietary supplementation of ARA-rich 
oil on fish growth, muscle, liver and whole body fatty acid distribution, liver morphology and lipid metabolism in 
European sea bass (Dicentrarchus labrax) as well as to evaluate the potential interactions with either EPA or DHA.  
 
2. Materials and methods 
2.1. Diets 
Five isolipidic and isoproteic experimental dry pelleted diets were prepared to contain graded levels of 
arachidonic acid (g fatty acid g
-1
 diet (dry weight)) as follows: 0.1 (ARA0.1; considered as negative control; C-), 0.2 
(ARA0.2), 0.4 (ARA0.4), 0.8 (ARA0.8) and 1.4 (ARA1.4). The desired ARA content was completed with 
commercially available ARA oil obtained from Mortierella alpina (Vevodar
®
, DSM Food Specialties, Netherlands). 
Supplementation of DHA and EPA was done using DHA50 and EPA50 (CRODA, East Yorkshire, UK). Diet 
ingredients, fatty acid profile and proximate composition are detailed in Tables 1 and 2.  
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Table 1. Experimental diets main ingredients (g·kg
-1
) and proximate composition.  
Ingredients  ARA0.1 (C-) ARA0.2 ARA0.4 ARA0.8 ARA1.4 
Fish Meal
1
 -- 52.50 52.50 52.50 52.50 
Fish oil
1
 -- 14.50 12.60 11.40 10.10 
Defatted Fish Meal
2
 46.50 -- -- -- -- 
Corn Meal
3
 7.00 6.00 6.00 6.00 6.00 
Soy 44 Meal
3
 10.00 10.00 10.00 10.00 10.00 
Wheat Meal
3
 5.50 5.50 5.50 5.50 5.50 
Wheat Gluten
3
 7.00 7.00 7.00 7.00 7.00 
Vegetable fats and oils
3
 14.50 -- -- -- -- 
Vitamins Mix 
4
 2.00 2.00 2.00 2.00 2.00 
Mineral Mix
5
 2.00 2.00 2.00 2.00 2.00 
CMC 
6
 0.50 0.50 0.50 0.50 0.50 
ARA
7
 -- -- 0.50 1.50 2.50 
DHA and EPA
8
 5.00 -- 1.40 1.60 1.90 
Diets Proximate composition (g·kg
-1
; d.w.)     
Crude Lipids  20.77 21.33 20.87 21.12 22.02 
Crude Protein 43.71 43.32 44.93 44.61 45.14 
Ash 9.75 10.51 10.47 10.39 10.49 
Moisture 8.94 6.57 7.63 7.25 7.39 
 
1Fish meal and oil, South American origin, (65% protein, 12% lipid). 
2 Defatted fish meal by 3 x chloroform extraction (73% protein, 2% lipid). 
3 Vegetable ingredients locally found (Soy 44 Meal: 46% protein, 3% lipid). 
4 Vitamin premix contains (mg kg-1 or IU kg-1 of dry diet): thiamine 40 mg, riboflavin 50 mg, pyridoxine 40 
mg, calcium pantothenate 117 mg, nicotinic acid 200 mg, biotin 1 mg, folic acid 10 mg, cyanocobalamin, 0.5 
mg, choline chloride 2700 mg, Myo-inositol 2000 mg, ascorbic acid 5000 mg, menadione 20 mg, 
cholecalciferol 2000 IU, ethoxyquin 100 mg, retinol acetate 5000 IU.  
5 Mineral premix contains (g kg-1 of dry diet): calcium orthophosphate 1.60 g, calcium carbonate 4 g, ferrous 
sulphate 1.5 g, magnesium sulphate 1.6 g, potassium phosphate 2.8 g, sodium phosphate 1 g, aluminium 
sulphate 0.02 g, zinc sulphate 0.24 g, copper sulphate 0.20 g, manganese sulphate 0.08 g, potassium iodate 
0.02 g.  
6 Carboxymethyl cellulose (sodium salt, Sigma-Aldrich, Munich, Germany).  
7 Vevodar®, DSM Food Specialties, Netherlands.  
8 DHA50 and EPA50, CRODA, East Yorkshire, UK. 
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Table 2. Fatty acids composition (g fatty acid · g
-1
 diet (dry weight)) of the experimental diets.  
 
ARA0.1 (C-) ARA0.2 ARA0.4 ARA0.8 ARA1.4 
14:0 0.04 0.97 1.04 1.01 0.94 
16:0 1.28 3.53 3.78 3.78 3.67 
18:0 0.66 0.84 0.95 1.03 1.11 
Total Saturates1 2.04 5.62 6.07 6.12 6.02 
16:1n-7 0.06 1.23 1.26 1.21 1.14 
18:1n-9 3.60 3.70 3.82 3.81 3.76 
18:1n-7 0.18 0.64 0.66 0.64 0.61 
20:1n-7 0.15 0.54 0.54 0.51 0.48 
22:1n-11 0.04 0.48 0.44 0.42 0.38 
Total Monoenes2 4.14 6.95 7.08 6.93 6.68 
18:2n-6 2.90 1.25 1.25 1.28 1.35 
18:3n-6 0.01 0.07 0.09 0.12 0.16 
20:2n-6 0.03 0.08 0.08 0.09 0.09 
20:3n-6 0.01 0.03 0.05 0.09 0.13 
20:4n-6 0.12 0.22 0.42 0.85 1.40 
22:5n-6 0.11 0.10 0.10 0.10 0.12 
Total n-6 PUFA3 3.21 1.79 2.03 2.57 3.30 
18:3n-3 8.78 0.34 0.33 0.29 0.28 
18:4n-3 0.02 0.30 0.23 0.22 0.22 
20:3n-3 0.05 0.04 0.04 0.03 0.03 
20:4n-3 0.03 0.14 0.12 0.11 0.11 
20:5n-3 0.43 2.06 1.60 1.55 1.68 
22:5n-3 0.12 0.39 0.29 0.28 0.31 
22:6n-3 1.90 3.12 2.54 2.51 2.86 
Total n-3 PUFA4 11.3
3 
6.60 5.33 5.16 5.68 
Ʃ n-3 LC-PUFA 2.52 5.75 4.59 4.48 5.00 
ARA/EPA 0.29 0.11 0.26 0.55 0.83 
EPA/ARA 3.49 9.37 3.78 1.82 1.20 
DHA/ARA 15.4
9 
14.2
2 
6.00 2.95 2.05 
n-3/n-6 3.53 3.69 2.62 2.01 1.72 
1Contains 15:0, 17: 0 and 20:0; 2Contains 14:1n-5, 14:1n-7, 15:1n-5, 16:1n-5, 18:1n-5; 20:1n-5; 20:1n-9 and 22:1n-9; 3Contains 16:2n-6 
and 22:4n-6; 4Contains 16:3n-3 and 16:4n-3.  
2.2. Experimental conditions 
Eight hundred and forty European sea bass juveniles were maintained in stocking tanks and fed a commercial 
diet for 4 weeks before starting the feeding trial. Afterwards, with an initial weight and length of 13.4 ± 0.3 g and 9.9 ± 
0.1 cm (mean ± SD) animals were randomly allocated in 15 indoor cylindroconical 200 L tanks (56 fish/tank; 3.7 kg·m
-3
 
initial stocking density). Tanks were supplied with filtered sea water at a temperature of 22.8–24.9 °C in a flow-through 
system and natural photoperiod (12L:12D). Water dissolved oxygen ranged between 7.3 and 8.1 ppm. Fish were 
manually fed until apparent satiation with one of the five experimental diets for 70 days (3 times a day, 6 days a week). 
Each dietary treatment was assayed in triplicate.  
Sampling was performed after 30 and 70 days of feeding. The whole fish population was individually sampled for 
final weight and length after 24 h of starvation. At the end of the feeding trial, 8 fish per tank were sampled for somatic 
indexes calculation and livers and fillets pooled and used for lipid content and fatty acid analyses. Besides, 3 pools of 5 
fish at the beginning of the experiment and 5 fish per tank at the end of the feeding trial were sampled for whole body 
nutrient retention calculations. Five fish per tank were sampled individually for liver morphological analyses. 
Additionally, livers of five fish per tank were taken and quickly kept in RNA later and frozen at -80 ºC until gene 
expression analysis. The animal experiments described comply with the guidelines of the European Union Council 
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(86/609/EU) and Spanish legislation (RD 1201/2005) for the use of laboratory animals and have been approved by the 
Bioethical Committee of the University of Las Palmas de Gran Canaria. 
 
2.3 Proximate composition and fatty acid analyses 
 
Feeds, whole body and tissue proximate composition analyses were conducted following standard procedures 
(AOAC 2000). Crude protein content (N x 6.25) was determined by Kjeldahl method and crude lipid was analyzed as 
described by Folch et al. (1957). Moisture was determined by thermal dehydration to constant weight at 110ºC. Ash 
content was determined by combustion at 600ºC for 12h. Fatty acid methyl esters profiles were prepared by 
transmethylation (Christie 2003) and separated by gas chromatography (GC-14A, Shimadzu, Japan) following the 
conditions described by Izquierdo et al. (1992). Fatty acid methyl esters quantification was performed by a flame 
ionizator detector and identification by comparison with external and well-characterized fish oils standards (EPA 28, 
Nippai, Ltd Tokyo, Japan). All analyses were conducted in triplicate.  
 
2.4 Liver morphological studies 
Individual liver samples were fixed in 4 % neutral-buffered formalin, embedded in paraffin and stained with 
haematoxilin and eosin (H&E) for optical examination (Martoja and Martoja-Pearson 1970). Liver steatosis level was 
evaluated by two scientists unaware of the dietary treatments based on hepatocyte vacuolization level and nuclei 
displacement and alignment around sinusoidal spaces grade. Micrographs were taken at a final magnification of 40X 
using an Olympus Cx41 microscope and an Olympus XC50 camera. 
 
2.5 RNA extraction and real-time PCR analysis 
Total RNA of fish liver was extracted using TRI reagent (Sigma-Aldrich, Saint Louis, MO, USA), quantified by 
measuring absorbance at 260 nm in a spectrophotometer (Nanodrop 1000, Thermo Fisher Scientific Inc., USA). The 
RNA integrity was verified by Gel Red™ staining (Biotium Inc., Hayward, CA) on a 1% agarose gel. The reverse 
transcription (RT) reactions were performed using the iScript
TM
 cDNA Synthesis Kit (Bio-Rad Hercules, California) in 
20 µl final volume containing 1 µg of total RNA. fads2, fabp7, hmgrc and gck gene expression was analyzed by real-
time PCR, using elongation factor-1 alpha (ef-1a) as housekeeping under the conditions described by Geay et al. (2011). 
Specific primers used and annealing temperatures (ºC) are indicated in Table 3. The PCR program consisted of an initial 
DNA denaturation of 94 °C for 90 s, followed by 45 cycles at 95 °C for 30 s and 60 °C for 60 s.All PCR reactions were 
carried out in a I-cycler with optical module (Bio-Rad Hercules, CA, USA) in a final volume of 20 μl, containing 10 μl 
Brillant SYBR Green QPCR Master Mix (Bio-Rad Hercules, CA, USA), 0.6 μl of each primer (10 mM) and 6.6 μl of 
cDNA (1:10 dilution).  
Each run was ended with a melting curve analysis resulting in a melting peak profile specific for the amplified 
target DNA. All reactions were performed in duplicate for each template cDNA. Blank control reactions replaced 
cDNA with water. Relative gene expression was estimated by the Δ-Δ method (Livak and Schimittgen 2001) in relation 
to fish fed 0.2ARA diet.  
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Table 3. Primers used for expression analyses by real-time PCR in liver of European sea bass (Dicentrarchus labrax) 
fed the different dietary treatments (t=70 days). The table shows: the gene accession number and the nucleotide 
sequences for each specific assay.  
Gene Accession # Forward  (5'3') Reverse (5'3') 
fads2 EU439924 CCTTCACTGCTCTTCATCCCAA CCCAGGTGGAGGCAGAAGAA 
gck AM986860 GGTGAAGCAAGCCTGAACTC  CTTCCAGCAGTGACTGTCCA 
fabp7 FM000669 GAAGGCACTTGGTGTTGGTT  CAGGGTTTTCACCACCACTT 
hmgrc AY424801 CCAGCTTCGTATTCAGCACA  GCTTTGGAGAGGTCGATGAG 
ef1a AJ866727 GCTTCGAGGAAATCACCAAG  CAACCTTCCATCCCTTGAAC 
fads2, fatty acid desaturase 2; gck, glycerol kinase; fabp7, fatty acid binding protein 7; hmgrc, 3-hydroxy-3-methylglutaryl-coenzyme 
A reductase; ef1a, elongation factor 1 alpha 
 
2.6 Statistical analysis 
All data were tested for normality and homogeneity of variance. Statistical analyses followed the methods 
described by Sokal and Rolf (1995). The significant level for all analyses was set at 5% and results are presented as 
means and standard deviations (SD), with exception of gene expression data that is presented as means and standard 
error (SE). If necessary, transformation of the data was performed. Data was submitted to a one-way analysis of 
variance (ANOVA). Two different statistical analyses were performed for all the parameters evaluated, including and 
excluding the negative control diet (ARA0.1). When F values showed significance, individual means were compared 
using post hoc tests for multiple means comparison. When variances were not homogeneous, non-parametric tests were 
applied. All analyses were performed using SPSS 21 software package for Windows (IBM, Chicago, IL, USA).  
 
3. Results 
3.1. Biological parameters 
On one side, feeding European sea bass with ARA0.1 along the trial (30 and 70 days) clearly reduced (P<0.05) 
fish total weight and length as well as specific growth rate (SGR) compared to fish fed higher ARA dietary levels 
(Table 4), however all fish presented similar condition factor (K) with exception of fish fed ARA0.1 and ARA0.2 after 
70 days of feeding (Table 4). Besides, fish fed ARA0.1 presented lower final perivisceral fat index (PFI) and 
hepatosomatic index (HSI) than fish fed diets ARA0.2 and ARA0.4, although it was similar to that presented by fish fed 
diets ARA0.8 and ARA1.4. 
On the other hand, for fish fed ARA dietary levels from 0.2 up to 1.4 (g fatty acid g
-1
 diet), no significant 
differences (P>0.05) were found for final weight, length, K and SGR. For somatic indexes, fish fed ARA0.2 presented 
higher viscerosomatic index (VSI), HSI and PFI than fish fed higher ARA levels, however HSI and PFI were not 
significantly different (P>0.05) from fish fed ARA0.4 (Fig. 1). Indeed, VSI (R=-0.803, n=12, P=0.002), HSI (R=-0.727, 
n=12, P=0.024) and PFI (R=-0.709, n=12, P=0.002) were significantly negatively correlated with dietary ARA content. 
Fish fed ARA0.2 diet presented the highest (P<0.05) final VSI compared to fish fed the rest of the dietary treatments 
(Table 4).  
Survival was high along the feeding trial for all the dietary treatments ranging from 93.3±4.6 % to 97.6±1.0%, with no 
significant differences observed (Table 4).  
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Table 4. Growth parameters, biometry and feed utilization of fish fed dietary graded level of arachidonic acid (ARA) 
along the feeding trial. 
 Diets 
  ARA0.1 (C-) ARA0.2 ARA0.4 ARA0.8 ARA1.4 
Initial (t=0days) 
     Weight (g) 13.3±0.2 13.3±0.3 13.6±0.5 13.4±0.2 13.5±0.1 
Length (cm) 9.8±0.1 9.8±0.0 9.9±0.1 9.9±0.1 9.9±0.0 
K 1.4±0.0 1.4±0.0 1.4±0.0 1.4±0.0 1.4±0.0 
Mid (t=30days) 
     Weight (g) 18.1±0.3a 21.9±0.6b 21.9±0.8b 21.9±1.2b 21.0±1.2b 
Length (cm) 11.0±0.1a 11.5±0.0b 11.6±0.1b 11.7±0.2b 11.5±0.1b 
K 1.3 ±0.0 1.4±0.0 1.4±0.0 1.4±0.0 1.4±0.0 
SGR (%) 0.9±0.1a 1.6±0.1b 1.5±0.1b 1.5±0.1b 1.4±0.2b 
Final (t=70 days) 
     Weight (g) 33.0±1.1a 44.4±1.1b 43.8±1.0b 43.9±3.7b 42.8±2.5b 
Length (cm) 13.9±0.1a 15.0±0.1b 15.0±0.0b 15.1±0.4b 15.0±0.3b 
K 1.2±0.0a 1.3±0.0b 1.3±0.0ab 1.3±0.0ab 1.3±0.0ab 
SGR (%) 1.3±0.0a 1.8±0.0b 1.7±0.1b 1.7±0.1b 1.7±0.1b 
Total survival (%) 97.0±2.1 93.3±4.6 96.4±3.1 97.0±3.8 97.6±1.0 
VSI 7.5±0.8a 12.4±1.8b 9.5±0.4a 7.7±0.8a 7.4±0.7a 
HSI 1.5±0.2a 2.4±0.5c 1.7±0.1bc 1.4±0.2ab 1.3±0.1ab 
PFI 4.7±0.6a 8.5±1.6c 6.6±0.4bc 5.4±0.7ab 5.1±0.4ab 
Values expressed in mean ± SD. (n = 3 tanks/diet). Different letters within a line denote significant differences among dietary treatments 
(P<0.05; one way ANOVA; Tukey). K, condition factor; SGR, specific growth rate; FCR, feed conversion ratio; PFI, perivisceral fat index; HSI, 
hepatosomatic index; VSI, viscerosomatic index.  
 
3.2. Tissue lipid content and fatty acid profiles 
3.2.1. Liver fatty acid profiles  
Dietary ARA levels did not significantly affect final liver lipid content (P>0.05) and liver fatty acid profile 
mostly mirrored that of the diet.  
On one hand, when comparing liver fatty acid profile of fish fed the negative control treatment (ARA0.1) with 
livers of fish the rest of the dietary treatments, fish fed diet ARA0.1 presented the lowest (P<0.05) saturated and 
monoenes and the highest (P<0.05) Ʃn-3 fatty acids levels (Table 5). No differences (P>0.05) were found for total liver 
n-3 LC-PUFA or DHA contents among livers of fish fed diets ARA0.1 up to ARA0.8, regardless of the 50-60 % lower 
dietary intake of total n-3 LC-PUFA for fish fed diet ARA0.1 (Table 2, Table 5). Besides, livers of fish fed ARA0.1 
showed a relative reduction of a 50-58% EPA in relation to the lower 70-80% EPA dietary percentage when compared 
with livers of fish fed the rest of the dietary treatments (Table 5). ARA hepatic content in fish fed ARA0.1 was similar 
to that presented by fish fed diet ARA0.2, despite that dietary content was relatively lower in a 45 %. Certainly, 20:3n-6 
and 18:4n-3 levels in liver of fish fed ARA0.1 were similar to those presented by fish fed ARA0.2 diet, regardless of the 
lower dietary content (Table 2, Table 5). Liver n-3/n-6 ratio tends to decrease as ARA liver content increases, 
presenting fish fed ARA1.4 diet the lowest (P<0.05).  
On the other hand, when comparing among profiles of hepatic fatty acid from fish fed ARA0.2 up to ARA1.4, 
fish fed ARA0.2 presented higher (P<0.05) monoenes and lower (P<0.05) Ʃn-6 fatty acids content than fish fed diet 
ARA0.8 and ARA1.4 diets, but not significantly different (P>0.05) from those presented by fish fed ARA0.4 diet 
(Table 5). No differences in saturated, Ʃn-3, n-3 LC-PUFA, EPA, DPA or DHA fatty acids were detected. However, 
dietary ARA amount was positively correlated with liver n-3 LC-PUFA (R=0.72, n=12, P=0.009), liver DHA (R=0.77, 
n=12, P=0.003) and liver DPA (R=0.58, n=12, P=0.047) content. Moreover, liver EPA content was positively 
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correlated with liver DPA (R=0.97, n=12, P=0.001) and DHA (R=0.88, n=12, P=0.001), as well as liver DPA and DHA 
amounts found (R=0.95, n=12, P=0.001). Ratio n-3/n-6 tended to decrease as ARA dietary content increased; with fish 
fed ARA1.4 presenting lower (P<0.05) values than fish fed ARA0.2 diet.  
 
 
Table 5. Liver lipid content (g·100 g
-1
 dry weight) and fatty acids profile (g fatty acid · g
-1
 tissue) of European sea bass 
(Dicentrarchus labrax) fed the experimental diets at the end of the feeding trial (t = 70 days) 
 
ARA0.1 (C-) ARA0.2 ARA0.4 ARA0.8 ARA1.4 
Lipids (d.w.) 55.05±3.21 50.04±0.86 45.89±1.12 50.12±2.16 51.06±1.41 
14:0 0.15±0.02
a 0.54±0.07b 0.65±0.07b 0.54±0.08b 0.61±0.04b 
16:0 1.68±0.12
a 4.01±0.38b 3.57±0.38b 3.29±0.10b 3.25±0.16b 
18:0 0.60±0.05
a 0.90±0.07b 0.83±0.07b 0.81±0.05b 0.86±0.03b 
Total Saturates1 2.49±0.13
a 5.59±0.50b 5.22±0.50b 4.79±0.17b 4.89±0.23b 
16:1n-7 0.25±0.02
a 1.14±0.08b 1.14±0.08b 1.02±0.09b 1.06±0.07b 
18:1n-9 4.04±0.39
a 6.17±0.26c/B 5.53±0.26bc/AB 5.15±0.55bc/AB 4.80±0.34ab/A 
18:1n-7 0.27±0.01
a 0.76±0.04c/B 0.75±0.04c/AB 0.70±0.03bc/AB 0.67±0.03bc/A 
20:1n-7 0.19±0.01
a 0.43±0.03c/A 0.46±0.03c/AB 0.39±0.01b/B 0.39±0.02b/AB 
22:1n-11 0.04±0.01
a 0.19±0.02bc/AB 0.21±0.02c/B 0.16±0.01b/A 0.17±0.01b/A 
Total Monoenes2 4.88±0.35
a 9.02±0.42c/B 8.42±0.42bc/AB 7.70±0.47b/A 7.38±0.42b/A 
18:2n-6 2.54±0.12
c 0.94±0.04a/AB 1.13±0.04ab/A 1.09±0.15b/AB 1.28±0.04ab/B 
18:3n-6 0.06±0.01
d 0.06±0.00d/A 0.07±0.00c/B 0.10±0.00b/C 0.13±0.00a/D 
20:2n-6 0.13±0.01
c 0.09±0.00a/A 0.10±0.00ab/AB 0.11±0.01ab/AB 0.12±0.01bc/B 
20:3n-6 0.02±0.00
a 0.02±0.00b/A 0.04±0.00c/B 0.07±0.01d/AB 0.11±0.00e/C 
20:4n-6 0.22±0.01
a 0.19±0.02a/A 0.35±0.02b/B 0.74±0.07c/C 1.20±0.04d/D 
22:5n-6 0.13±0.01
b 0.08±0.01a/A 0.10±0.01ab/AB 0.12±0.01b/B 0.13±0.01b/B 
Total n-6 PUFA3 3.12±0.11
a 1.43±0.06c/A 1.84±0.06bc/AB 2.29±0.24b/BC 3.03±0.06ab/C 
18:3n-3 6.04±0.11
b 0.22±0.01a 0.24±0.01a 0.21±0.02a 0.23±0.01a 
18:4n-3 0.14±0.03 0.14±0.02 0.14±0.02 0.13±0.00 0.14±0.01 
20:3n-3 0.08±0.01
b 0.03±0.00a 0.03±0.00a 0.03±0.00a 0.03±0.00a 
20:4n-3 0.04±0.00
a 0.10±0.01b 0.10±0.01b 0.10±0.01b 0.10±0.01b 
20:5n-3 0.57±0.07
a 1.22±0.20b 1.18±0.20b 1.29±0.01b 1.34±0.13b 
22:5n-3 0.18±0.02
a 0.32±0.06b 0.31±0.06b 0.36±0.01b 0.38±0.04b 
22:6n-3 3.09±0.28
a 2.81±0.61a 2.98±0.61a 3.81±0.12ab 4.09±0.43b 
Total n-3 PUFA4 10.16±0.42
b 4.90±0.89a 5.04±0.89a 6.00±0.14a 6.38±0.62a 
Ʃ n-3 LC-PUFA 3.96±0.36
a 4.48±0.87ab 4.59±0.87ab 5.59±0.13ab 5.95±0.60b 
ARA/EPA 0.39±0.03
b 0.15±0.03a/A 0.30±0.03b/B 0.58±0.05c/C 0.90±0.05d/D 
EPA/ARA 2.59±0.19
c 6.49±0.34e/C 3.35±0.34d/B 1.74±0.15b/A 1.12±0.07a/A 
DHA/ARA 14.01±0.60
d 14.87±1.14d/C 8.43±1.14c/B 5.16±0.31b/A 3.41±0.24a/A 
n-3/n-6 3.26±0.13
b 3.40±0.44b/B 2.74±0.44ab/AB 2.64±0.21ab/AB 2.11±0.19a/A 
Values expressed in mean ± SD. (n = 3 tanks/diet). Different upper case letters within a line denote significant differences among dietary treatments 
among fish fed ARA0.2 up to ARA1.4 (P<0.05; one way ANOVA; Tukey). Different lower case letters within a line denote significant differences 
among dietary treatments among fish fed ARA0.1 up to ARA1.4 (P<0.05; one way ANOVA; Tukey). 1Contains 15:0, 17: 0 and 20:0; 2Contains 
14:1n-5, 14:1n-7, 15:1n-5, 16:1n-5, 18:1n-5; 20:1n-5; 20:1n-9 and 22:1n-9; 3Contains 16:2n-6 and 22:4n-6; 4Contains 16:3n-3 and 16:4n-3.  
3.2.2. Muscle fatty acid profiles  
Dietary ARA levels did not significantly affect muscle lipid content (P>0.05) after 70 days of feeding and, in 
general terms, fatty acid profile mirrored that of the diet.  
On one hand, when comparing muscle fatty acid profile of fish fed the negative control treatment (ARA0.1) 
with muscle of fish the rest of the dietary treatments, fish fed diet ARA0.1 presented the lowest (P<0.05) saturated, 
monoenes and Ʃn-3 LC-PUFA and highest (P<0.05) Ʃn-3 levels. Ʃn-6 fatty acids muscle contents of fish fed negative 
control diet was similar to that presented by fish fed ARA1.4 diet, but higher (P<0.05) than fish fed the rest of the 
dietary treatments (Table 6). In contrast to liver, muscle of fish fed ARA0.1 diet presented an approximately 25 % less 
Ʃn-3 LC-PUFA content than muscle of fish fed higher levels of dietary ARA. Indeed, muscle of fish fed ARA0.1 
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presented a relative reduction of a 4-15% in DHA and a 50-55% in EPA content in relation to the lower 25-40 % DHA 
and 72-80 % EPA dietary percentage (Table 2, Table 6). Muscle ARA content in fish fed diet ARA0.1 was reduced by a 
15 %, 54 %, 76 % and 84 % compared to fish fed diets ARA0.2 up to ARA1.4 respectively, although dietary content 
was relatively lower in a 45 %, 71 %, 85 % and 91 % respectively (Table 2,Table 6). Actually, fish fed diet ARA0.1 
presented higher (P<0.05) muscle 20:3n-3 content compared to fish fed other dietary ARA percentages, despite similar 
dietary levels (Table 6). Muscle n-3/n-6 ratio tends to decrease as ARA dietary content increases, presenting fish fed 
ARA1.4 diet the lowest (P<0.05). 
On the other hand, by comparing dietary ARA levels from 0.2 up to 1.4 (g fatty acid g
-1
 diet), no differences 
(P>0.05) among dietary treatments were found for saturates, Ʃn-3 and Ʃn-3 LC-PUFA levels. Muscle of fish fed diet 
ARA0.2 presented the highest (P<0.05) monoens and lowest (P<0.05) Ʃn-6 fatty acids contents (Table 6). Similarly to 
liver, muscle EPA content was positively correlated with muscle DPA (R=0.99, n=12, P=0.001) and DHA (R=0.95, 
n=12, P=0.001), as well as liver DPA and DHA amounts found (R=0.97, n=12, P=0.001). Muscle n-3/n-6 tends to 
decrease as ARA liver content increases, however fish fed ARA0.2 and ARA0.4 diets presented similar values 
(P>0.05).  
 
Table 6. Muscle lipid content (g·100 g
-1
 dry weight) and fatty acids profile (g fatty acid g
-1
 tissue) of European sea bass 
(Dicentrarchus labrax) fed the experimental diets at the end of the feeding trial (t = 70 days) 
 
ARA0.1 (C-) ARA0.2 ARA0.4 ARA0.8 ARA1.4 
Lipids (d.w.) 18.87±1.11 16.00±4.90 22.57±4.71 22.32±6.54 14.55±3.08 
14:0 0.30±0.02
a 0.91±0.06b 0.83±0.06b 0.82±0.05b 0.82±0.04b 
16:0 2.82±0.19
a 4.50±0.16b 4.24±0.16b 4.14±0.12b 4.40±0.21b 
18:0 0.93±0.05
a 0.97±0.08a/AB 0.87±0.08a/A 0.98±0.13a/AB 1.14±0.11b/B 
Total Saturates1 4.16±0.20
a 6.61±0.17b 6.17±0.17b 6.18±0.19b 6.60±0.35b 
16:1n-7 0.46±0.06
a 1.28±0.09b 1.19±0.09b 1.15±0.04b 1.14±0.01b 
18:1n-9 4.58±0.15 4.90±0.10 4.75±0.10 4.65±0.14 4.75±0.19 
18:1n-7 0.35±0.02
a 0.70±0.02c/B 0.65±0.02bc/A 0.65±0.01b/A 0.65±0.02bc/A 
20:1n-7 0.28±0.01
a 0.53±0.03b 0.50±0.03b 0.50±0.01b 0.49±0.02b 
22:1n-11 0.07±0.01
a 0.31±0.03c 0.28±0.03bc 0.29±0.01bc 0.26±0.02b 
Total Monoenes2 5.89±0.24
a 8.06±0.18c/B 7.70±0.18b/A 7.56±0.11b/A 7.61±0.15b/A 
18:2n-6 2.33±0.10
b 1.29±0.08a 1.31±0.08a 1.34±0.03a 1.42±0.08a 
18:3n-6 0.03±0.00
a 0.04±0.00abc/A 0.07±0.00b/AB 0.09±0.00c/B 0.11±0.00d/C 
20:2n-6 0.13±0.00
a 0.11±0.00b/AB 0.11±0.00b/A 0.11±0.01ab/AB 0.12±0.00ab/B 
20:3n-6 0.01±0.01
a 0.02±0.00b/A 0.04±0.00c/B 0.07±0.00d/C 0.09±0.01e/D 
20:4n-6 0.16±0.01
a 0.19±0.04b/A 0.35±0.04c/B 0.69±0.02d/C 1.00±0.06e/D 
22:5n-6 0.10±0.00
c 0.08±0.00a/A 0.09±0.00b/B 0.10±0.00bc/B 0.10±0.00bc/B 
Total n-6 PUFA3 2.79±0.09
d 1.77±0.04a/A 2.00±0.04b/B 2.43±0.01c/C 2.89±0.03d/D 
18:3n-3 4.67±0.47
b 0.32±0.01a 0.29±0.01a 0.26±0.01a 0.27±0.02a 
18:4n-3 0.08±0.01
a 0.16±0.02b 0.15±0.02b 0.14±0.02b 0.14±0.01b 
20:3n-3 0.06±0.01
b 0.04±0.00a 0.04±0.00a 0.03±0.00a 0.03±0.01a 
20:4n-3 0.04±0.00
a 0.09±0.01b 0.09±0.01b 0.09±0.01b 0.08±0.00b 
20:5n-3 0.58±0.07
a 1.28±0.05b 1.24±0.05b 1.19±0.13b 1.17±0.06b 
22:5n-3 0.14±0.00
a 0.27±0.01b 0.26±0.01b 0.26±0.02b 0.25±0.02b 
22:6n-3 2.16±0.04
a 2.25±0.16ab 2.47±0.16b 2.53±0.12b 2.53±0.17b 
Total n-3 PUFA4 7.76±0.36
b 4.52±0.08a 4.65±0.08a 4.60±0.30a 4.58±0.28a 
Ʃ n-3 LC-PUFA 2.98±0.10
a 3.93±0.11b 4.11±0.11b 4.10±0.25b 4.07±0.25b 
ARA/EPA 0.28±0.02
b 0.15±0.04a/A 0.28±0.04b/B 0.58±0.06c/C 0.85±0.07d/D 
EPA/ARA 3.56±0.24
b 6.67±0.52c/C 3.59±0.52b/B 1.74±0.18a/A 1.18±0.10a/A 
DHA/ARA 13.38±0.91
d 11.69±0.30c/D 7.12±0.30b/C 3.69±0.08a/B 2.55±0.28a/A 
n-3/n-6 2.78±0.05
e 2.56±0.07d/C 2.32±0.07c/C 1.89±0.13b/B 1.59±0.08a/A 
Values expressed in mean ± SD. (n = 3 tanks/diet). Different upper case letters within a line denote significant differences among dietary treatments 
among fish fed ARA0.2 up to ARA1.4 (P<0.05; one way ANOVA; Tukey). Different lower case letters within a line denote significant differences 
among dietary treatments among fish fed ARA0.1 up to ARA1.4 (P<0.05; one way ANOVA; Tukey). 1Contains 15:0, 17: 0 and 20:0; 2Contains 
14:1n-5, 14:1n-7, 15:1n-5, 16:1n-5, 18:1n-5; 20:1n-5; 20:1n-9 and 22:1n-9; 3Contains 16:2n-6 and 22:4n-6; 4Contains 16:3n-3 and 16:4n-3. 
  
11 
 
3.2.3. Whole body fatty acid profiles  
Dietary ARA levels did not significantly affect whole body lipid content (P>0.05) and whole body fatty acid 
profile generally reflected that of the diet.  
On one hand, by comparing dietary ARA levels from 0.1 up to 1.4 g fatty acid · g
-1
 diet, fish fed diet ARA0.1 
presented the lowest (P<0.05) saturated, monoenes and Ʃn-3LC-PUFA and the highest (P<0.05) Ʃn-3 and Ʃn-6 fatty 
acids levels (Table 7). Fish fed ARA0.1 and ARA0.2 diets presented similar whole body ARA and DHA contents, 
despite of a relative lower 45% and 40% dietary percentage, respectively. Indeed, whole body DHA relative content in 
fish fed ARA0.1 was only a 5-17% lower than DHA percentages in fish fed higher dietary ARA levels, regardless of the 
lower 25-40% dietary percentage fed. Similarly, whole body composition of fish fed ARA0.1 diet resulted in a EPA 
relative reduction of approximately a 50% compared to fish fed the rest of the dietary treatments, despite the lower 70-
80% EPA dietary content. Whole body n-3/n-6 ratio tends to decrease as ARA dietary content increases, presenting fish 
fed ARA1.4 diet the lowest (P<0.05).  
On the other hand, excluding negative control treatment, fish fed diet ARA0.2 presented the highest (P<0.05) 
monoenes and the lowest Ʃn-6 levels. Indeed, whole body monoenes and Ʃn-3LC-PUFA levels were positively 
correlated (R=0.77, n=12, P=0.003) among them. No differences (P>0.05) among dietary treatments were found for Ʃn-
3 levels and fish fed diet ARA0.2 presented lower Ʃn-3LC-PUFA level than fish fed diet ARA0.4, but it was not 
significantly different (P<0.05) from that presented by fish fed diets ARA0.8 and ARA1.4 (Table 7). Whole body ARA 
content increased accordingly with ARA dietary levels and similarly to muscle and liver, whole body EPA content was 
positively correlated with muscle DPA (R=0.94, n=12, P=0.001) and DHA (R=0.78, n=12, P=0.003), as well as liver 
DPA and DHA amounts found (R=0.84, n=12, P=0.001). Whole body n-3/n-6 tended to decrease as ARA dietary 
content increased, however fish fed ARA0.2 and ARA0.4 diets presented similar values (P>0.05) as detected in muscle.  
Table 7. Whole body lipid content (g·100 g
-1
 dry weight) and fatty acids profile (g fatty acid · g
-1
 tissue) of European 
sea bass (Dicentrarchus labrax) fed the experimental diets at the end of the feeding trial (t = 70 days) 
 
ARA0.1 (C-) ARA0.2 ARA0.4 ARA0.8 ARA1.4 
Lipids (d.w.)      
14:0 0.30±0.02
a 0.84±0.03b 0.80±0.03b 0.79±0.00b 0.79±0.04b 
16:0 2.14±0.09
a 3.66±0.05c/B 3.40±0.05b/A 3.44±0.02b/A 3.56±0.09bc/AB 
18:0 0.65±0.01
a 0.75±0.02bc/AB 0.72±0.02b/A 0.78±0.03c/B 0.85±0.02d/C 
Total Saturates1 3.19±0.10
a 5.47±0.09c/B 5.14±0.09b/A 5.24±0.05bc/AB 5.42±0.15c/B 
16:1n-7 0.48±0.03
a 1.24±0.02c/B 1.18±0.02bc/AB 1.14±0.02b/A 1.15±0.04b/A 
18:1n-9 4.20±0.02
a 4.75±0.09c/B 4.37±0.09ab/A 4.31±0.02a/A 4.54±0.09b/AB 
18:1n-7 0.34±0.01
a 0.66±0.02c 0.62±0.02b 0.60±0.01b 0.60±0.01b 
20:1n-7 0.30±0.01
a 0.53±0.01c/B 0.51±0.01c/B 0.47±0.02b/A 0.47±0.02b/A 
22:1n-11 0.10±0.01
a 0.34±0.02c/B 0.31±0.02bc/AB 0.27±0.02b/A 0.26±0.03b/A 
Total Monoenes2 5.56±0.07
a 7.85±0.10c/B 7.29±0.10b/A 7.09±0.06b/A 7.31±0.12b/A 
18:2n-6 2.34±0.07
c 1.39±0.01a/AB 1.33±0.01a/A 1.41±0.04a/B 1.51±0.04b/C 
18:3n-6 0.03±0.00
a 0.04±0.00b/A 0.05±0.00c/B 0.08±0.00d/C 0.10±0.00e/D 
20:2n-6 0.13±0.01
b 0.11±0.00a 0.11±0.00a 0.11±0.00a 0.11±0.00a 
20:3n-6 0.02±0.00
a 0.03±0.00a/A 0.04±0.00b/B 0.07±0.01c/C 0.10±0.01d/D 
20:4n-6 0.17±0.04
d 0.19±0.01d/A 0.36±0.01c/B 0.70±0.01b/C 1.02±0.02a/D 
22:5n-6 0.11±0.01
a 0.09±0.00b/A 0.11±0.00b/B 0.11±0.00b/B 0.11±0.00b/B 
Total n-6 PUFA3 2.83±0.02
a 1.88±0.01b/A 2.04±0.01c/B 2.52±0.06d/C 3.01±0.02e/D 
18:3n-3 5.11±0.25
a 0.41±0.01b 0.32±0.01b 0.31±0.01b 0.32±0.01b 
18:4n-3 0.11±0.01
a 0.23±0.01c/B 0.21±0.01bc/AB 0.20±0.01b/A 0.20±0.01b/A 
20:3n-3 0.06±0.00
b 0.03±0.00a 0.03±0.00a 0.03±0.00a 0.03±0.00a 
20:4n-3 0.06±0.00
a 0.12±0.00c/B 0.12±0.00c/B 0.11±0.00b/A 0.11±0.00b/A 
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20:5n-3 0.79±0.04
a 1.67±0.07b 1.66±0.07b 1.62±0.07b 1.61±0.07b 
22:5n-3 0.20±0.02
a 0.36±0.01b 0.37±0.01b 0.35±0.00b 0.35±0.01b 
22:6n-3 2.65±0.14
a 2.80±0.07a 3.20±0.07b 3.18±0.06b 3.18±0.10b 
Total n-3 PUFA4 9.01±0.17
b 5.73±0.14a 6.02±0.14a 5.91±0.14a 5.91±0.18a 
Ʃ n-3 LC-PUFA 3.76±0.20
a 4.99±0.13b/A 5.38±0.13c/B 5.28±0.13bc/AB 5.28±0.16bc/AB 
ARA/EPA 0.21±0.04
b 0.11±0.01a/A 0.22±0.01b/B 0.44±0.03c/C 0.63±0.03d/D 
EPA/ARA 4.85±0.86
b 8.86±0.20c/D 4.58±0.20b/C 2.30±0.14a/B 1.58±0.07a/A 
DHA/ARA 16.42±3.13
c 14.82±0.38c/D 8.84±0.38b/C 4.52±0.15a/B 3.11±0.07a/A 
n-3/n-6 3.18±0.07
d 3.04±0.07cd/C 2.94±0.07c/C 2.34±0.11b/B 1.96±0.05a/A 
Values expressed in mean ± SD. (n = 3 tanks/diet). Different upper case letters within a line denote significant differences among dietary treatments 
among fish fed ARA0.2 up to ARA1.4 (P<0.05; one way ANOVA; Tukey). Different lower case letters within a line denote significant differences 
among dietary treatments among fish fed ARA0.1 up to ARA1.4 (P<0.05; one way ANOVA; Tukey). 1Contains 15:0, 17: 0 and 20:0; 2Contains 
14:1n-5, 14:1n-7, 15:1n-5, 16:1n-5, 18:1n-5; 20:1n-5; 20:1n-9 and 22:1n-9; 3Contains 16:2n-6 and 22:4n-6; 4Contains 16:3n-3 and 16:4n-3. 
 
3.3. Liver Morphology 
Qualitative morphological evaluation revealed an effect of dietary ARA level on the liver morphology of 
European sea bass fed the different dietary treatments. Fish fed the negative control diet presented the highest steatosis 
level when compared to fish fed diets containing higher ARA dietary levels, which presented a moderate to low 
steatosis level (Fig. 2). This pattern was more evident in fish fed diets ARA0.4, ARA0.8 and ARA1.4 which, in general 
terms, presented a more regular-shaped morphology around sinusoidal spaces and a reduction of intracytoplasmatic 
lipid vacuolization resulting in decreased number of hepatocytes with the nuclei displaced to the cellular periphery (Fig. 
2b). Fish fed diet ARA0.2 presented an intermediate morphological pattern.  
 
3.4. Liver lipid metabolism related gene expression 
In general terms, an up regulation in the expression of the studied genes could be observed in livers of fish fed 
ARA0.1 in relation to livers of fish fed the rest of the dietary treatments. Particularly, fish fed diet ARA0.1 presented a 
significant up-regulation (P<0.05) of hmgcr and fads2 compared to the rest of the dietary treatments (Fig. 3). When 
comparing fish fed diets ARA0.2 up to ARA1.4, no significant (P>0.05) differences were observed for the genes 
studied.  
4. Discussion 
Dietary supplementation of ARA from 0.2 up to 1.4  (g fatty acid  g
-1
 diet) did not affect European sea bass 
growth performance and survival after 70 days of feeding when supplemented in a high FM/FO based diet (n-3 LC-
PUFA 4.5-5.7 and n-6 LC-PUFA 0.3-1.6 (g fatty acid g
-1
 diet). This finding is in agreement with previous studies in 
juvenile Atlantic salmon fed dietary ARA levels from 0.2 up to 0.8 (g fatty acid g
-1
 diet) for 12 weeks supplemented in 
low FO diets (Dantagnan et al. 2017), in young gilthead sea bream (Sparus aurata) fed for 54 days increased levels of 
dietary ARA (0.03 up to 1.68 (g fatty acid g
-1
 diet) in 100 % VO diet (Fountoulaki et al., 2003) and in gobid 
(Synechogobius hasta) fed for 8 weeks levels from a 0.9 up to 6.5  (g fatty acid g
-1
 diet) in a 48%FM/0%FO based diet 
(Luo et al. 2012). However fish fed the negative control diet, which totally replaced FO content and contained defatted 
FM, presented reduced growth just only 30 days after the start of the feeding trial. Similarly, decreased growth has been 
observed in European sea bass fed total replacement of dietary FM and FO by plant based ingredients (Geay et al., 
2011; Le Boucher et al., 2011, 2013; Torrecillas et al., 2017). Particularly, Torrecillas et al. (2017) found a clear 
reduction of weight gain in juvenile European sea bass fed for 90 days a diet without FM and FO (n-3 LC-PUFA 0.14 
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% and n-6 LC-PUFA 0.02 g fatty acid g
-1
 diet). However supplementation with LC-PUFA (n-3 LC-PUFA 1.1 % and n-
6 LC-PUFA 0.16 g fatty acid g
-1
 diet) led to increased growth (Torrecillas et al., 2017) denoting the important role of 
LC-PUFA on fish growth (Izquierdo and Koven, 2011). Not only a deficiency but also an excess of dietary LC-PUFA 
may lead to reduced fish growth performance. For instance, Japanese sea bass (Lateolabrax japonicus) fed ARA dietary 
supplementation greater than 0.7 % g fatty acid g
-1
 diet in zero FO diets for 12 weeks resulted in reduced growth 
performance despite containing similar n-3 LC-PUFA percentages (Xu et al. 2010). It is not clear why ARA affects 
growth in fish but it has been speculated that ARA can modulate the growth through altering the ratio of prostaglandin 
E2 (PGE2) and prostaglandin F2a (PGF2a; Palmer 1990) related with alterations on muscle fiber formation and protein 
degradation (Bell and Sargent 2003). Indeed, it has been suggested that some of the discrepancies reported for dietary 
ARA effects on fish growth performance may be related to low EPA dietary levels (Norambuena et al., 2016). In this 
sense, Atlantic salmon fed proportions of ARA:EPA around 1:4.2 significantly increased weight gain when compared 
to fish fed low or high ratios of ARA and EPA (1:1.5 and 1:9) after 14 weeks of feeding (Norambuena et al., 2016). 
However, when supplemented for a total of 20 weeks fish fed the lowest ARA:EPA ratio were similar in weight gain to 
fish fed 1:4.2 ARA:EPA ratio. In the present trial no differences were found in growth performance despite the dietary 
difference in the ARA:EPA ratio among fish fed diet ARA0.2 (1:8.8) and fish fed higher dietary ARA levels, however 
the effect of ARA:EPA ratio on European sea bass growth productivity in a long-term feeding study must be evaluated 
before concluding in relation to this particular subject .  
When comparing among ARA-supplemented groups, fish fed ARA0.2 presented higher levels of lipid 
deposition as denoted by higher PFI, HSI and VSI indexes meanwhile there was a reduction in lipid deposition with 
enhanced levels of dietary ARA. Indeed there was a strong linear correlation between dietary ARA levels and the 
indexes (HSI: -0.73, n=12, P=0.024; VSI: -0.80, n=12, P=0.002; PFI: -0.79, n=12, P=0.002) when the feed absent in 
ARA was exempted from the analysis. Similar results have been observed in other teleost species where increasing 
levels of dietary ARA levels were negatively correlated with lipid deposition in whole body and individual tissues 
(Castell et al. 1994; Fountoulaki et al. 2003; Xu et al. 2010; Luo et al. 2012). In fact, it has been suggested that dietary 
ARA may reduce lipid accumulation and inhibit biosynthesis of fatty acids (Norambuena et al., 2016). In this sense, 
grass carp (Ctenopharyngodon idellus) fed diets containing intermediate levels of ARA (0.3 g fatty acid g
-1
 diet) 
showed higher PFI than fish fed lower or higher ARA levels (0.03 and 0.6 g fatty acid g
-1
 diet; Tian et al. 2014). 
Additionally, Japanese sea bass showed a significant decrease in HSI and a trend to reduced VSI with increasing dietary 
levels of ARA (0.36 up to 2.24 g fatty acid g
-1
 diet; Xu et al. 2010) in FM/VO supplemented with EFA enriched oils 
diet, similarly to what was observed in the present trial, with the exemption of fish fed negative control diet, where the 
reduced HSI could be probably attributed to the nutritional status of the fish. Indeed, the trend to higher accumulation of 
perivisceral fat and increased VSI and HSI observed in fish fed ARA0.2, is in concordance with the trend to the greater 
lipid vacuolization of the cytoplasm observed in relation to fish fed higher dietary ARA levels and lower ARA:EPA 
ratios.  
Generally the fatty acid profiles of fish tissues reflect those of the diets, being this particularly true in marine 
fish species with a reduced LC-PUFA biosynthesis activity. In this sense, differences in the fatty acid profile among 
tissues could indicate physiological relevance of that fatty acid for that particular tissue. In the present study the 
incorporation of ARA in tissue total lipids did not vary among the evaluated tissues, ARA increasing when increasing 
in diet. Previous studies with differing dietary ARA levels showed a selective incorporation into several organs other 
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than liver and muscle, which are of special importance on immune defence, such as gills, kidney, head kidney 
leucocytes and plasma (Castell et al. 1994; Betancor et al. 2014: Torrecillas et al., 2017b). The role of ARA on immune 
system function involves effects on cell membrane fluidity and stability, ion transport, trafficking and vesicular 
transport, membrane-associated enzymes activities, alterations of gene-encoding proteins involved in lipid metabolism 
or activation of NADPH oxidase activity (Torrecillas et al., 2017b). Besides, eicosanoids derived from ARA increase 
vascular permeability and vasodilatation, induce leucocytes chemotaxis and promote generation of reactive oxygen 
species (ROS) (Calder et al., 2006). 
Muscle is a storage tissue and as expected its fatty acid profile reflected dietary contents in agreement with 
previous studies (Izquierdo et al. 2003; Montero et al. 2005; Torrecillas et al. 2016; Betancor et al. 2016b), although 
levels of some fatty acids such as EPA, DHA and ARA were found in higher proportion in fish flesh than in the feeds 
for fish fed the negative control diet. Indeed, ARA and DHA content in flesh and whole body for fish fed diets ARA0.1 
and ARA0.2 was similar regardless of the different dietary content, despite ARA is a minor component of membranes 
in fish compared to EPA and DHA and is mainly stored in polar lipids (Tocher, 2010; Norambuena et al., 2016). 
Besides, EPA content was positively correlated with muscle and whole body DPA and DHA content when negative 
control was exempted from the analysis. Altogether may be indicating not only a selective accumulation of DHA, but 
also pointing to a functional n-3 LC-PUFA biosynthesis towards DHA.  
Liver is considered an important site for LC-PUFA synthesis and lipid metabolism in fish (Monroig et al. 
2010) and is expected that differences in feed fatty acid profile may elicit changes in this tissue. For fish fed reduced 
levels of n-3 LC-PUFA in combination with increased levels of C18 fatty acids (negative control diet), the evident liver 
morphological pattern alteration observed is in agreement with previous studies in this (Torrecillas et al., 2016; 2017) 
and other Mediterranean fish species (Caballero et al., 2003). Despite of seeming to indicate that the negative control 
diet did not fulfil European sea bass nutritional requirements for a proper growth performance with consequences in 
liver health status, signs of a selective accumulation of DHA and an active n-3 LC-PUFA biosynthesis could be 
observed in their liver as indicated by the lack of differences in the DHA contents among fish fed diets ARA0.1 up to 
ARA 0.8 as well as enhanced liver contents of the intermediate product 18:4n-3, which may indicate an certain activity 
of elongases and desaturases involved in LC-PUFA biosynthesis. Indeed, when negative control diet was exempted 
from the analysis, n-3LC-PUFA, DPA and DHA liver content were positively correlated with dietary ARA and liver 
DPA and liver EPA was positively correlated with liver DPA and DHA. Additionally, increased expression of fads2 
was significantly higher in ARA0.1-fed fish particularly when compared to fish fed ARA0.8. In order to achieve 
isolipidic feeds, high levels of VO were used in the formulation of ARA0.1, which consequently generated high levels 
of C18 fatty acids in the feeds and reduced levels of not only ARA, but also EPA and DHA. This is the reason why it 
was expectable to find an up-regulation in the expression of fads2 in fish fed the lowest LC-PUFA levels as observed in 
previous studies substituting FO by VO blends in European sea bass (González-Rovira et al. 2009; Geay et al. 2010; 
Castro et al. 2015). As fads2 also participates in the desaturation of 18:2n-6 to 18:3n-6 (Monroig et al. 2010), enhanced 
levels of this intermediate product were also found in the liver of fish fed ARA0.1 feeds compared to dietary content, 
indicating additional biosynthesis towards n-6 LC-PUFA. Indeed, liver ARA content was positively correlated with 
liver 18:3n-6 (R=0.98, n=16; P<0.001). The reason why levels of ARA differed greatly in the liver among fish fed the 
different dietary treatment whereas DHA levels were the same could be due to higher preference of fads2 towards 
18:3n-3 rather than 18:2n-6 as has been proved in vitro (14.5 % versus 5.6 %; González-Rovira et al. 2009). It must be 
noted though that the European sea bass, as a carnivorous marine fish has a marine fish pattern in the metabolism of 
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LC-PUFA meaning that has limited capacity to convert C18 fatty acids to ARA, EPA and DHA (González-Rovira et al. 
2009). Thus, the small rates of LC-PUFA produced are not enough to enhance whole body or flesh levels of DHA, EPA 
or ARA. Another lipid metabolism related gene that was up-regulated in fish fed negative control diet was hmgcr, the 
rate-limiting enzyme in cholesterol biosynthesis (Le Martelot et al. 2009). Up-regulation in genes belonging to the 
cholesterol pathway has been previously described in fish fed more sustainable feeds (Geay et al. 2011; Betancor et al. 
2015a) particularly those containing high levels of VO as this is naturally low in cholesterol and can contain 
cholesterol-lowering phytosterols (Gilman et al. 2003). Thus, the enhancement in the expression of hmgcr in fish fed 
ARA0.1, low in dietary n-3 and n-6 PUFA content and with high percentages 18:2n-6 and 18:3n-3 as consequence of 
not contain FO, may correspond to a compensatory mechanism in order to produce the cholesterol levels necessary to 
fulfil fish requirements rather than a direct effect of the lack of ARA. These findings are in agreement with previous 
studies in Atlantic salmon, in which FO replacement by VO elicits not only liver compositional changes but also 
metabolic alterations in HUFA and cholesterol biosynthetic pathways in order to compensate for deficiencies in the 
diet, being fads2, srebp-1 and srebp-2 especially up-regulated (Leaver et al., 2008; Morais et al., 2011).  
The expression of fabp7, a gene related to fatty acid transport and uptake tended to be up-regulated in liver of sea bass 
fed ARA0.1, although no differences could be observed among the other dietary treatments. In a similar trial where sea 
bass were fed diets containing high levels of terrestrial ingredients showed an up-regulation in this gene (Geay et al. 
2011) and sea bream and cod fed plant-based feed showed up-regulation in fabp2 when fed on more sustainable feeds 
(Lilleeng et al. 2007; Betancor et al. 2016b). Additionally, these fish also showed the lowest performance, what could 
be suggesting that the up-regulation in fabp7 expression may be associated with the lower growth of these fish, which in 
turn could elicit compensatory mechanisms such as fatty acid mobilization. ARA did not show to regulated the hepatic 
expression of gck, a phosphotranferase enzyme involved in triglycerides and glycerophospholipids synthesis although 
there was a trend for an up-regulation in the liver if fish were fed with the negative control diet. Previous studies in 
salmonids have also found an up-regulation in the expression of gck when fish were fed terrestrial-ingredient diets 
(Panserat et al. 2009; Morais et al. 2011) and it was hypothesized that it was related to higher lipid biosynthesis in liver. 
In the present trial the higher lipid vacuolization degree in liver was observed in fish fed the lower dietary ARA levels 
and thus seems the result of activation in triglyceride synthesis although not directly elicited by gck as no differences 
were found in terms of gene expression.  
In summary, dietary ARA levels up to a 0.2 g fatty acid g
-1
 diet seem to be necessary to fulfil juvenile sea bass 
requirements for this fatty acid and guarantee proper growth. Increasing ARA levels between a 0.2  and a 1.4 g fatty 
acid g
-1
 diet did not enhance fish growth or survival, but levels over a 0.2 g fatty acid g
-1
 diet seemed to inhibit 
triglyceride biosynthesis as reduced PFI, HSI and VSI was observed. An up-regulation in the hepatic expression of 
fads2 in fish fed the lowest ARA levels (0.1 g fatty acid g
-1
 diet) seemed to be related not only to desaturation of 18:2n-
6 to 18:3n-6 but also from 18:3n-3 to 18:4n-3 as also levels of n-3 LC-PUFA were low in this feed. Additionally an up-
regulation in the expression of hmgcr, the rate limiting enzyme in cholesterol biosynthesis, was observed in the liver of 
ARA0.1-fed fish what seems to indicate the response of fish to low levels of dietary cholesterol although a direct effect 
of ARA on the regulation of hmgcr cannot be excluded as has been found in mammals. Results from the present study 
point out the necessity to include adequate levels of n-6 LC-PUFA in diets for European sea bass juveniles. Therefore 
there the new alternatives to FO investigated should aim to contain not only adequate levels of n-3 LC-PUFA but also 
n-6 LC-PUFA.  
  
16 
 
5. Acknowledgements 
This work was fund by the Spanish Ministry of Economy and Competitiveness (MINECO). Project 
AGL2012-39919 (PROINMUNOIL). Complementary it has been financed through a ULPGC postdoctoral 
fellowship (PICULPGC-2013-CIENCIAS, concept 643.00.06) and a predoctoral fellowship (ULPGC-2013).   
 
6. References 
AOAC (2000) Official Methods of Analysis. Association of Official Analytical Chemists, Washington, DC  
Atalah E, Hernández-Cruz CM, Benítez-Santana T, Ganga R, Roo J, Izquierdo M (2011) Importance of the relative 
levels of dietary arachidonic acid and eicosapentaenoic acid for culture performance of gilthead seabream 
(Sparus aurata) larvae. Aquaculture Research 42, 1279-1288. doi:10.1111/j.1365-2109.2010.02716.x 
Bell JG, Sargent JR (2003) Arachidonic acid in aquaculture feeds: current status and future opportunities. Aquaculture 
218:491-9. doi:10.1016/S0044-8486(02)00370-8 
Bessonart M, Izquierdo MS, Salhi M, Hernández-Cruz CM, González MM, Fernández-Palacios H (1999) Effect of 
dietary arachidonic acid levels on growth and survival of gilthead sea bream (Sparus aurata L.) larvae. 
Aquaculture 179, 265-275. doi:10.1016/S0044-8486(99)00164-7 
Betancor MB, Howarth FJE, Glencross BD, Tocher DR (2014) Influence of dietary docosahexaenoic acid in 
combination with other long-chain polyunsaturated fatty acids on expression of biosynthesis genes and 
phospholipid fatty acid compositions in tissues of post-smolt Atlantic salmon (Salmo salar). Comparative 
Biochemistry and Physiology 172-173B, 74-89. doi:10.1016/j.cbpb.2014.04.007 
Betancor MB, Sprague M, Montero D, Usher S, Sayanova O, Campbell PJ, Napier JA, Caballero MJ, Izquierdo M, 
Tocher DR (2016b) Replacement of marine fish oil with de novo omega-3 oils from transgenic Camelina 
sativa in feeds for gilthead sea bream (Sparus aurata L.). Lipids 51, 1171-1191. doi:10.1007/s11745-016-
4191-4 
Betancor MB, Sprague M, Sayanova O, Usher S, Campbell PJ, Napier JA, Caballero MJ & Tocher DR (2015b) 
Evaluation of a high-EPA oil from transgenic Camelina sativa in feeds for Atlantic salmon (Salmo salar L.): 
Effects on tissue fatty acid composition, histology and gene expression. Aquaculture 444, 1-12. 
doi:  10.1016/j.aquaculture.2015.03.020 
Betancor MB, Sprague M, Sayanova O, Usher S, Metochis C, Campbell PJ, Napier JA, Tocher DR (2016a) Nutritional 
evaluation of an EPA-DHA oil from transgenic Camelina sativa in feeds for post-smolt Atlantic salmon 
(Salmo salar L.). PLoS ONE 11, e0159934. doi:10.1371/journal.pone.0159934 
Betancor MB, Sprague M, Usher S, Sayanova O, Campbell PJ, Napier JA & Tocher DR (2015a) A nutritionally-
enhanced oil from transgenic Camelina sativa effectively replaces fish oil as a source of eicosapentaenoic acid 
for fish. Scientific Reports 5, 8104. doi:10.1038/srep08104 
Boglino A, Wishkerman A, Darias MJ, de la Iglesia P, Andree KP, Gisbert E, Estévez A (2014) Senegalese sole (Solea 
senegalensis) metamorphic larvae are more sensitive to pseudo-albinism induced by high dietary arachidonic 
acid levels than post-metamorphic larvae. Aquaculture 433:276-87. doi:10.1016/j.aquaculture.2014.06.012 
Caballero MJ, Gallardo G, Robaina L, Montero D, Fernández A, Izquierdo M (2006) Vegetable lipid sources affect in 
vitro biosynthesis of triacylglycerols and phospholipids in the intestine of sea bream (Sparus aurata). British 
Journal of Nutrition 95, 448-454. doi:10.1079/BJN20051529 
Caballero MJ, Obach A, Rosenlund G, Montero E, Gisvold M, Izquierdo MS (2002) Impact of different dietary lipid 
sources on growth, lipid digestibility, tissue fatty acid composition and histology of rainbow trout, 
Oncorhynchus mykiss. Aquaculture 214, 253-271. doi: 10.1016/S0044-8486(01)00852-3 
Calder PC (2006)  N-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of 
Clinical Nutrition 83(6):S1505-19S. 
Calder PC (2008) The relationship between the fatty acid composition of immune cells and their function. 
Prostaglandins Leukot Essent Fat Acids 79, 101-108. doi:10.1016/j.plefa.2008.09.016 
Carrier JK, Watanabe WO, Harel M, Rezek TC, Seaton PJ, Shafer TH (2011) Effects of dietary arachidonic acid on 
larval performance, fatty acid profiles, stress resistance, and expression of Na+/K+ ATPase mRNA in black 
sea bass Centropristis striata. Aquaculture 319, 111-121. doi:10.1016/j.aquaculture.2011.06.027 
  
17 
Castell JD, Bell JG, Tocher DR, Sargent JR (1994) Effects of purified diets containing different combinations of 
arachidonic and docosahexaenoic acid on survival, growth and fatty acid composition of juvenile turbot 
(Scophtalmus maximus). Aquaculture 128, 315-333. doi:10.1016/0044-8486(94)90320-4 
Castro C, Corraze G, Panserat S, Oliva-Teles A (2015) Effects of fish oil replacement by a vegetable oil blend on 
digestibility, postpandrial serum metabolite profile, lipid and glucose metabolism of European sea bass 
(Dicentrarchus labrax) juveniles. Aquaculture Nutrition 21, 592-603. doi:10.1111/anu.12184 
Christie WW (2003) Lipid Analysis, third ed. Oily Press, Bridgwater  
Dantagnan P, González K, Hevia M, Betancor MB, Hernández AJ, Borquez A, Montero D (2017) Effect of the 
arachidonic acid/vitamin E interaction on the immune response of juvenile Atlantic salmon (Salmo salar) 
challenged against Piscirickettsia salmonis. Aquaculture Nutrition, 23: 710-720 .doi: 10.1111/anu.12438 
Folch J, Lees N, Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipids from 
animal tissues. J Biol Chem 226: 497–509. 
Fountoulaki E, Alexis MN, Nengas I, Venou B (2003) Effects of dietary arachidonic acid (20:4n-6) on growth, body 
composition and tissue fatty acid profile of gilthead sea bream fingerlings (Sparus aurata L.). Aquaculture 
225, 309-323. doi: 10.1016/S0044-8486(03)00298-9 
Froyland, L., Lie, O., Berge, R.K. (2000) Mitochondrial and peroxisomal beta-oxidation capacities in various tissues 
from Atlantic salmon Salmo salar. Aquacult. Nutr., 6, 85-89. doi:10.1046/j.1365-2095.2000.00130.x 
Furuita H, Yamamoto T, Shima T, Suzuki N, Takeuchi T (2003) Effect of arachidonic acid levels in broodstock diet on 
larval and egg quality of Japanese flounder Paralichthys olivaceus. Aquaculture 220, 725-35. doi: 
10.1016/S0044-8486(02)00617-8 
Geay F, Ferraresso S, Zambonino-Infante JL, Bargelloni L, Quentel C, Vandeputte M, Kaushik S, Cahu CL, mazurais 
D (2011) Effects of the total replacement of fish-based diet with plant-based diet on the hepatic transcriptome 
of two European sea bass (Dicentrarchus labrax) half-sibfamilies showing different growth rates with the 
plant-based diet. BMC Genomics 12, 522. doi:10.1186/1471-2164-12-522 
Geay F, Santigosa E, Corporeau C, Boudry P, Dreano Y, Corcos L, Bodin N, Vandeputte M, Zambonino-Infante JL, 
Mazurais D, Cahu CL (2010) Regulation of FADS2 expression and activity in European sea bass 
(Dicentrarchus labrax) fed a vegetable oil. Comparative Biochemistry and Physiuology Part B: Biochemistry 
and Molecular Biology 156, 237-243. doi:10.1016/j.cbpb.2010.03.008  
Gilman CI, Leusch FD, Breckenridge WC, MacLatchy DL (2003) Effects of a phytosterol mixture on male fish plasma 
lipoprotein fractions and testis P450scc activity. Gen Comp Endocrinol 130, 172-184. doi:10.1016/S0016-
6480(02)00590-7 
González-Rovira A, Mourent G, Zheng X, Tocher DR, Pendon C (2009) Molecular and functional characterization and 
expression analysis of a delta-6 fatty acyl desaturase cDNA of European sea bass (Dicentrarchus labrax L.). 
Aquaculture 298, 90-100. doi:10.1016/j.aquaculture.2009.10.012 
Higgs DA, Dong FM (2000) Lipids and fatty acids. The encyclopedia of aquaculture. JohnWiley and Sons, New York, 
USA pp. 476-96. 
Izquierdo MS, Arakawa T, Takeuchi T, Haroun R, Watanabe T (1992) Effect of n-3 HUFA levels in Artemia on growth 
of larval Japanese flounder (Paralichthys olivaceous). Aquaculture Nutrition 2, 183-191. doi:10.1016/0044-
8486(92)90163-F 
Izquierdo, M.S., Obach, A., Arantzamendi, L., Montero, D., Robaina, L.E. & Rosenlund, G. (2003) Dietary lipid 
sources for seabream and sea bass: growth performance, tissue composition and flesh quality. Aquacult. Nutr., 
9, 397–407. doi:10.1046/j.1365-2095.2003.00270.x 
Izquierdo MS,  Koven, 2011. Lipids. Larval Fish Nutrition. Holt J. (Ed). Oxford: Wiley-Blackwell, John Wiley and 
Sons Publisher, 2011. pp. 47-82.   
Kiron V, Thawonsuwan J, Panigrahi A, Scharsack J, Satoh S (2011) Antioxidant and immune defences of rainbow trout 
(Oncorhynchus mykiss) offered plant oils differing in fatty acid profiles from early stages. Aquacult. Nutr. 17, 
130-40. doi:10.1111/j.1365-2095.2009.00715.x 
Koven W, Anholt RV, Lutzsky S, Atia IB, Nixon O, Ron B, et al. (2003) The effect of dietary arachidonic acid on 
growth, survival, and cortisol levels in different-age gilthead seabream larvae Sparus auratus exposed to 
handling or daily salinity change. Aquaculture 228, 307-20. doi: 10.1016/S0044-8486(03)00317-X 
Koven W, Barr Y, Luzky S, Ben-Atia I, Weiss R, Harel M, et al. (2001) The effect of dietary arachidonic acid (20:4n-6) 
on growth, survival and resistance to handling stress in gilthead seabream (Sparus aurata) larvae. Aquaculture 
193, 107-22. doi:10.1016/S0044-8486(00)00479-8 
Leaver MJ, Villeneuve LAN, Obach A; Jensen L, Bron JE, Tocher DR, Taggart JB (2008) Functional genomics reveals 
increases in cholesterol biosynthetic genes and highly unsaturated fatty acid biosynthesis after dietary 
substitution of fish oil with vehetable oils in Atlantic salmon (Salmo salar). BMC Genomics 9, 299 
doi:10.1186/1471-2164-9-299 
Le Boucher, R., Vandeputte, M., Dupont-Nivet, M., Quillet, E., Mazurais, D., Robin, J., Vergnet, A., Médale, F., 
Kaushik, S., Chatain, B., 2011. A first insight into genotype × diet interactions in European sea bass 
(Dicentrarchus labrax L. 1756) in the context of plant-based diet use. Aquac. Res. 42, 583-92. 
  
18 
Le Boucher, R., Vandeputte, M., Dupont-Nivet, M., Quillet, E., Ruelle, F., Vergnet, A., Kaushik, S., Allamellou, M., 
Médale, F., Chatain, B., 2013. Genotype by diet interactions in European sea bass (Dicentrarchus labrax L.): 
Nutritional challenge with totally plant-based diets. J. Anim. Sci. 91, 44-56. 
Le Martelot G, Claudel T, Gatfield D, Schaad O, Kornman, Lo Sasso G, Moschetta A, Schibler U (2009) REV-ERB 
alpha participates in circadian SREBP signalling and bile acid homeostasis. PLOS Biol 7. 
doi:10.1371/journal.pbio.1000181 
Lilleeng E, Frøystad MK, Vekterud K, Valen EC, Krogdahl Å (2007) Comparison of intestinal gene expression in 
Atlantic cod (Gadus morhua) fed standard fish meal or soybean meal by means of suppression subtractive 
hybridization and real-time PCR. Aquaculture 267: 269-283. doi: 10.1016/j.aquaculture.2007.01.048 
Livak KJ, Schimittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2
-
ΔΔCt
 method. Methods 25, 402-408. doi:10.1006/meth.2001.1262 
Lund I, Steenfeldt SJ, Hansen BW (2007) Effect of dietary ARA, EPA and DHA on the fatty acid composition, 
survival, growth and pigmentation of larvae of common sole (Solea solea L.). Aquaculture 273, 532-44. doi: 
10.1016/j.aquaculture.2007.10.047 
Lund I, Steenfeldt SJ, Hansen BW (2010) Influence of dietary arachidonic acid combined with light intensity and tank 
colour on pigmentation of common sole (Solea solea L.) larvae. Aquaculture 308, 159-65. doi: 
10.1016/j.aquaculture.2010.08.004 
Luo Z, Tan XY, Li XD, Yin G-J (2012) Effect of dietary arachidonic acid levels on growth performance, hepatic fatty 
acid profile, intermediary metabolism and antioxidant responses for juvenile Synechogobius hasta. 
Aquaculture Nutrition 18, 340-348. doi: 10.1111/j.1365-2095.2011.00906.x 
Martins DA, Rocha F, Martínez-Rodríguez G, Bell G, Morais S, Castanheira F, Bandarra N, Coutinho J, Yúfera M, 
Conceição L (2012) Teleost fish larvae adapt to dietary arachidonic acid supply through modulation of the 
expression of lipid metabolism and stress response genes. British Journal of Nutrition 108, 864-874. doi: 
10.1017/S0007114511006143 
Martoja R, Martoja-Pearson M (1970) Técnicas de Histología Animal. Toray-Masson S.A. (Ed.) Barcelona 
Monroig O, Zheng X, Morais S, Leaver MJ, Taggart JB, Tocher DR (2010) Multiple genes for functional Δ6 fatty acyl 
desaturases (Fad) in Atlantic salmon (Salmo salar L.): Gene and cDNA characterization, functional expression, 
tissue distribution and nutritional regulation. Biochim Biophys Acta 1801, 1072-1081. 
doi:10.1016/j.bbalip.2010.04.007 
Montero D, Izquierdo MS (2010) Welfare and health of fish fed vegetable oils as alternative lipid sources to fish oil. In: 
Turchini, G., Ng, W. and Tocher, D. (ed) Fish Oil Replacement and Alternative Lipid Sources in Aquaculture 
Feeds. Cambridge, UK: CRC Press. p. 439-85.  
Montero D, Terova G, Rimoldi S, Betancor MB, Atalah E, Torrecillas S, Caballero MJ, Zamorano MJ, Izquierdo M 
(2015) Modulation of the expression of components of the stress response by dietary arachidonic acid in 
European sea bass (Dicentrarchus labrax) larvae. Lipids 50, 1026-1041. doi:10.1007/s11745-015-4057-1 
Montero, D., Robaina, L.E., Caballero, M.J., Gin_es, R. & Izquierdo, M.S. (2005) Growth, feed utilization and flesh 
quality of European sea bass (Dicentrarchus labrax) fed diets containing vegetable oils. A time-course study on 
the effects of re-feeding period with a 100% fish oil diet. Aquaculture, 248, 121–134. 
doi:10.1016/j.aquaculture.2005.03.003 
Morais S, Pratoomyot J, Taggart JB, Bron JE, Guy DR, Bell JG, Tocher DR (2011) Genotype-specific responses in 
Atlantic salmon (Salmo salar) subject to dietary fish oil replacement by vegetable oil: a liver transcriptomic 
analysis. BMC Genomics 12: 255. doi: 10.1186/1471-2164-12-255. 
Mourente G, Dick JR, Bell JG, Tocher DR (2005) Effects of partial substitution of dietary fish oil by vegetable oils on 
desaturation and β-oxidation of [1-14-C] 18:3n-3 (LNA) and [1-14C] 20:5n-3 (EPA) in hepatocytes and 
enterocytes of European sea bass (Dicentrarchus labrax L.) Aquaculture248, 173-186. 
doi:10.1016/j.aquaculture.2005.04.023 
Norambuena F, Estévez A, Sánchez-Vázquez FJ, Carazo I, Duncan N (2012) Self-selection of diets with different 
content of arachidonic acid by Senegalese sole (Solea senegalensis) broodstock. Aquaculture 364, 198-205. 
doi:10.1016/j.aquaculture.2012.08.016 
Norambuena F, Rombenso A, Turchini GM (2016) Towards the optimization of Atlantic salmon reared at different 
water temperatures via the manipulation of dietary ARA/EPA ratio. Aquaculture 450: 48-57. doi: 
10.1016/j.aquaculture.2015.06.044 
Norambuena F. Lewis M, Hadid NKA, Hermon K, Donald JA, Turchini GM (2013) Fish oil replacement in current 
aquaculture feed: Is cholesterol a hidden treasure for fish nutrition? PLoS ONE 8, e81705. doi: 
10.1371/journal.pone.0081705 
Palmer RM (1990) Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandins Leukot 
Essent Fatty Acids 39, 95-104. doi: 10.1016/0952-3278(90)90017-F 
Panserat S, Hortopan GA, Plagnes-Juan E, Kolditz C, Lansard M, Skiba-Cassy S, Esquerré D, Geurden I, Médale F, 
Kaushik S, Corraze G (2009) Differential gene expression after total replacement of dietary fish meal and fish 
  
19 
oil by plant products in rainbow trout (Oncorhynchus mykiss) liver. Aquaculture 294, 123-131. doi: 
10.1016/j.aquaculture.2009.05.013 
Rezek TC, Watanabe WO, Harel M, Seaton PJ (2010) Effects of dietary docosahexaenoic acid (22:6n-3) and 
arachidonic acid (20:4n-6) on the growth, survival, stress resistance and fatty acid composition in black sea 
bass, Centropristis striata (Linnaeus 1758) larvae. Aquaculture Research 41, 1302-1314. doi: 10.1111/j.1365-
2109.2009.02418.x 
Rombenso AN, Trushenki JT, Jirsa D, Drawbridge M (2016) Docosahexaenoic acid (DHA) and arachidonic acid 
(ARA) are essential to meet LC-PUFA requirements of juvenile California Yellowatil (Seriola dorsalis). 
Aquaculture 463, 123-134. doi: 10.1016/j.aquaculture.2016.05.004 
Salini MJ, Wade NM, Araújo BC, Turchini GM, Glencross BD (2016) Eicosapentaenoic acid, arachidonic acid and 
eicosanoid metabolism in juvenile Barramundi Lates calcarifer. Lipids 51, 973-988. doi: 10.1007/s11745-016-
4167-4. 
Smith WL, Murphy RC, Dennis E,Vance JEV (2002) The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase 
pathways. In: Krebs J. and Michalak M. (ed) New Comprehensive Biochemistry, 36, 341-371.  
Sokal RR, Rolf SJ (1995) Biometry. In: Taylor & Francis (ed) The principles and practice of statistics in biological 
research, 3rd edn. New York: Freeman, p. 419. 
Tian JJ, Ji H, Oku H, Zhou JS (2014) Effects of dietary arachidonic acid (ARA) on lipid metabolism and health status 
of juvenile grass carp, Ctenopharyngodon idellus. Aquaculture 430, 57-65. doi: 
10.1016/j.aquaculture.2014.03.020 
Tocher DR (2010) Fatty acid requirements in ontogeny of marine and freshwater fish. Aquaculture Research 41, 717–
732. doi: 10.1111/j.1365-2109.2008.02150.x 
Torrecillas S, Caballero MJ, Montero D, Sweetman J, Izquierdo MS. Combined effects of dietary mannan 
oligosaccharides and total fish oil substitution by soybean oil on European sea bass (Dicentrarchus labrax) 
juvenile diets. Aquaculture Nutrition 2016 22; 1079–1090. DOI: 10.1111/anu.12322 
Torrecillas S, Robaina L, Caballero MJ, Montero D, Calandra G, Mompel D, Karalazos V, Kaushik S, Izquierdo M.S 
(2017) Combined replacement of fishmeal and fish oil in European sea bass (Dicentrarchus labrax): Production 
performance, tissue composition and liver morphology. Aquaculture 474 101–112. DOI: 
10..1016/j.aquaculture.2017.03.031. 
Torrecillas S, Román L, Rivero-Ramírez F, Caballero MJ, Pascual C, Robaina L, Izquierdo MS, Acosta F, Montero D. 
(2017) Supplementation of arachidonic acid rich oil in European sea bass juveniles (Dicentrarchus labrax) 
diets: Effects on leucocytes and plasma fatty acid profiles, selected immune parameters and circulating 
prostaglandins levels. Fish Shellfish Immunology 64, 437-445. DOI: 10.1016/j.fsi.2017.03.041 
Waagbø R (2006) Feeding and disease resistance in fish. In: Mosenthin R., Zentek J. and Żebrowska T. (ed) Biology of 
Nutrition in Growing Animals, 4, 387-415.  
Xu H, Ai Q, Mai K, Xu W, Wang J, Ma H, Zhang W, Wang X, Liufu Z (2010) Effects of dietary arachidonic acid on 
growth performance, survival, immune response and tissue fatty acid composition of juvenile Japanese 
seabass, Lateolabrax japonicus. Aquaculture 307, 75-82. DOI: 10.1016/j.aquaculture.2010.07.001 
Yuan YH, Li SL, Mai KS, Xu W, Zhang YJ, Ai QH (2015) The effect of dietary arachidonic acid (ARA) on growth 
performance. Fatty acid composition and expression of ARA metabolism-related genes in larval half-smooth 
tongue sole (Cynoglossus semilaevis). British Journal of Nutrition 113, 1518-1530. doi: 
10.1017/S0007114515000781. 
 
 
 
Figure legends 
Figure 1. (A)Viscerosomatic index (VSI), (B) hepatosomatic index (HSI) and (C) perivisceral fat index (PFI) of 
European sea bass (Dicentrarchus labrax) at the end of the feeding trial (70 days).  
Figure 2. Hepatocytes (H&E, scale bar: 200 μm) morphology of European sea bass (Dicentrarchus labrax) at the end 
of the feeding trial (70 days); (a) morphological pattern observed in fish fed diets ARA0.1 and ARA0.2 and (b) 
morphological pattern observed in fish fed ARA0.4, ARA0.8 and ARA1.4 diets.  
Figure 3. Liver relative gene expression of European sea bass (Dicentrarchus labrax) (a) fabp7 (b) fads2, (c) hmgrc 
and (d) gck at the end of the feeding trial (70 days). Data expressed (mean±SE) relatively to fish fed ARA0.2 diet.  
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